IL18 and pancreatic neoplasm: The evidence presented in this study shows that NLRP3-regulated IL-18-induced eosinophilic inflammation may be involved in promoting the pathogenesis of pancreatic neoplasm via the indicated pathways and promotes characteristics similar to human cancer.